| |
|
|
| Name: |
Vestal Point Capital LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10012 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
48 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NBIX |
Neurocrine Biosciences Inc |
1 |
- |
$135.99 |
$105,408,000 |
800,000 |
11.17% |
0 |
0 |
0.856 |
Biotechnology |
|
|
JAZZ |
Jazz Pharmaceuticals Inc |
2 |
- |
$109.27 |
$89,175,000 |
725,000 |
9.45% |
0 |
0 |
1.186 |
Biotechnology |
|
|
ASND |
Ascendis Pharma AS |
3 |
- |
$135.90 |
$78,719,000 |
625,000 |
8.34% |
0 |
0 |
0.967 |
N/A |
|
|
INBX |
Inhibrx, Inc. |
4 |
- |
$0.00 |
$58,140,000 |
1,530,000 |
6.16% |
0 |
0 |
4.057 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
5 |
- |
$0.16 |
$52,325,000 |
1,300,000 |
5.54% |
0 |
0 |
1.633 |
N/A |
|
|
MRK |
Merck & Co Inc |
6 |
- |
$131.20 |
$43,608,000 |
400,000 |
4.62% |
0 |
0 |
0.016 |
Drug Manufacturers - ... |
|
|
GMED |
Genomed Inc |
7 |
- |
$50.55 |
$42,632,000 |
800,000 |
4.52% |
0 |
0 |
1.049 |
N/A |
|
|
PCRX |
Pacira Pharmaceuticals, Inc. |
8 |
- |
$26.33 |
$40,488,000 |
1,200,000 |
4.29% |
0 |
0 |
2.427 |
Drug Manufacturers - ... |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
9 |
- |
$32.48 |
$38,383,000 |
1,625,000 |
4.07% |
0 |
0 |
1.715 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
10 |
- |
$0.00 |
$32,970,000 |
525,000 |
3.49% |
0 |
0 |
0.487 |
N/A |
|
|
INSM |
Insmed Inc |
11 |
- |
$24.80 |
$27,891,000 |
900,000 |
2.95% |
0 |
0 |
0.594 |
Biotechnology |
|
|
QURE |
uniQure B.V. |
12 |
- |
$4.53 |
$26,572,000 |
3,925,000 |
2.81% |
0 |
0 |
8.82 |
N/A |
|
|
ALXO |
Alx Oncology Holdings Inc |
13 |
- |
$0.00 |
$24,643,000 |
1,655,000 |
2.61% |
0 |
0 |
3.322 |
N/A |
|
|
IMTX |
Immatics N.V |
14 |
- |
$10.01 |
$22,113,000 |
2,100,000 |
2.34% |
0 |
0 |
3.338 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
15 |
- |
$12.88 |
$21,780,000 |
1,000,000 |
2.31% |
0 |
0 |
2.206 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
16 |
- |
$35.96 |
$20,793,000 |
725,000 |
2.2% |
0 |
0 |
0.633 |
N/A |
|
|
BIIB |
Biogen Idec Inc |
17 |
- |
$208.90 |
$19,408,000 |
75,000 |
2.06% |
0 |
0 |
0.049 |
Biotechnology |
|
|
EW |
Edwards Lifesciences Corp |
18 |
- |
$29.43 |
$17,156,000 |
225,000 |
1.82% |
0 |
0 |
0.036 |
Medical Appliances & ... |
|
|
AZN |
AstraZeneca Plc (ADR) |
19 |
- |
$75.17 |
$16,838,000 |
250,000 |
1.78% |
0 |
0 |
0.01 |
Drug Manufacturers - ... |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
20 |
- |
$42.12 |
$16,011,000 |
450,000 |
1.7% |
0 |
0 |
0.776 |
N/A |
|
|
LYRA |
Lyra Therapeutics, Inc. |
21 |
- |
$0.00 |
$15,720,000 |
3,000,000 |
1.67% |
0 |
0 |
5.708 |
N/A |
|
|
SNY |
Sanofi Aventis (ADR) |
22 |
- |
$49.13 |
$14,919,000 |
300,000 |
1.58% |
0 |
0 |
0.012 |
Drug Manufacturers - ... |
|
|
NUVL |
Nuvalent, Inc. |
23 |
- |
$0.00 |
$14,718,000 |
200,000 |
1.56% |
0 |
0 |
0.351 |
N/A |
|
|
APLT |
Applied Therapeutics Inc. |
24 |
- |
$0.00 |
$13,919,000 |
4,155,000 |
1.47% |
0 |
0 |
8.654 |
N/A |
|
|
LQDA |
Liquidia Technologies Inc |
25 |
- |
$12.53 |
$12,331,000 |
1,025,000 |
1.31% |
0 |
0 |
2.715 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
26 |
- |
$0.00 |
$9,052,000 |
400,000 |
0.96% |
0 |
0 |
1.509 |
N/A |
|
|
REGN |
Regeneron Pharmaceuticals Inc |
27 |
- |
$883.20 |
$8,783,000 |
10,000 |
0.93% |
0 |
0 |
0.01 |
Biotechnology |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
28 |
- |
$8.47 |
$8,721,000 |
2,700,000 |
0.92% |
0 |
0 |
3.595 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
29 |
- |
$0.00 |
$8,061,000 |
175,000 |
0.85% |
0 |
0 |
0.28 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
30 |
- |
$0.00 |
$6,919,000 |
1,025,000 |
0.73% |
0 |
0 |
1.626 |
N/A |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
31 |
- |
$143.31 |
$6,699,000 |
35,000 |
0.71% |
0 |
0 |
0.028 |
Biotechnology |
|
|
GLPG |
Galapagos NV - ADR |
32 |
- |
$28.76 |
$5,285,000 |
130,000 |
0.56% |
0 |
0 |
0.199 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
33 |
- |
$3.80 |
$4,825,000 |
1,290,000 |
0.51% |
0 |
0 |
1.089 |
Biotechnology |
|
|
CYTK |
Cytokinetics Inc |
34 |
- |
$65.34 |
$4,175,000 |
50,000 |
0.44% |
0 |
0 |
0.044 |
Biotechnology |
|
|
ACLX |
Arcellx, Inc. |
35 |
- |
$0.00 |
$3,330,000 |
60,000 |
0.35% |
0 |
0 |
0.123 |
N/A |
|
|
BLUE |
Bluebird Bio, Inc. |
36 |
- |
$0.92 |
$2,967,000 |
2,150,000 |
0.31% |
0 |
0 |
2.102 |
Biotechnology |
|
|
TEVA |
Teva Pharmaceutical Industr... |
37 |
- |
$13.81 |
$2,088,000 |
200,000 |
0.22% |
0 |
0 |
0.018 |
Drug Manufacturers - ... |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
38 |
- |
$0.70 |
$1,404,000 |
135,000 |
0.15% |
0 |
0 |
0.911 |
N/A |
|
|
CMRX |
Chimerix Inc |
39 |
- |
$0.90 |
$1,348,000 |
1,400,000 |
0.14% |
0 |
0 |
2.251 |
Biotechnology |
|
|
PYXS |
Pyxis Oncology, Inc. |
40 |
- |
$0.00 |
$792,000 |
440,000 |
0.08% |
0 |
0 |
1.343 |
N/A |
|
|
RPHM |
Reneo Pharmaceuticals, Inc. |
41 |
- |
$1.67 |
$640,000 |
400,000 |
0.07% |
0 |
0 |
1.647 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
42 |
- |
$0.00 |
$636,000 |
322,671 |
0.07% |
0 |
0 |
1.071 |
N/A |
|
|
RLMD |
Relmada Therapeutics, Inc. |
43 |
- |
$3.83 |
$476,000 |
115,000 |
0.05% |
0 |
0 |
0.415 |
N/A |
|
|
AFMD |
Affimed Nv |
44 |
- |
$0.61 |
$34,100 |
54,607 |
0.04% |
0 |
0 |
0.474 |
N/A |
|
|
OVID |
Ovid Therapeutics Inc. |
45 |
- |
$3.10 |
$275,000 |
85,429 |
0.03% |
0 |
0 |
0.135 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
46 |
- |
$8.98 |
$209,000 |
34,085 |
0.02% |
0 |
0 |
0.174 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
47 |
- |
$4.43 |
$180,000 |
20,306 |
0.02% |
0 |
0 |
0.021 |
N/A |
|
|
ACHL |
Achilles Therapeutics Ameri... |
48 |
- |
$0.00 |
$96,000 |
108,083 |
0.01% |
0 |
0 |
0.266 |
N/A |
|
